Foundation for Spike Protein Long Covid and Microvascular Research Inc
Nonprofit profile at a glance
- EIN
- 932125003
- IRS 990-EZ coverage
- 2023–2024
- Forms available
- Form 990-EZ 2024
- Location
- Birmingham, AL, USA
- Phone
- 2059097690
- Rating
- 48
- Verdict
- MIXED
- Rating confidence
- Moderate
- Sector
- Medical Disciplines Research
Reported finances
- Revenue
- $71,544
- Expenses
- $1,050
- Assets
- $70,494
- Liabilities
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
5 people listed
People named in this filing
- JORDAN VAUGHN (DIRECTOR, PRES., TREAS.)
- HENRY RAY (DIRECTOR & VP)
- LAURA SINK (DIRECTOR & SECRETARY)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Perform scientific research regarding severe acute respiratory syndrome coronavirus 2, the existence of persistent symptoms of the same virus past its acute phase, and related endothelial dysfunction of the microvasculature and deposition of micro clot complexes in small capillaries. Publish and disseminate scientfic literature regarding the same and educate medical practitioners and the general public.
What it reported doing in 2024
Funding of several large equipment purchases for research & diagnositcs and clinical trials. Ecp bed approximately 20k to serve the participants in our pilot study. Immunoflourescent microscope to determine amyloid fibrin coagulation persistence in long covid individuals
Operating model
- Revenue model
- Donor-supported. 100% of the money available for current operations came from contributions and gifts.
- Distribution model
- No current program activity. The filing reports no program spending for the current year.
The verdict
MIXED - The filed numbers largely add up and revenue comfortably covers expenses. A relatively small share of available resources goes toward mission work and a relatively small share of total spending goes to programs.
Rating breakdown
- Financial Efficiency: 0
- Transparency & Controls: 100
- Sustainability: 91
- Growth: 60
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 0%; rating input score 0
- Program expense ratio: 0%; rating input score 0
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
Sustainability
- Operating margin: 98.5%; rating input score 100; 100th percentile among comparable filings
- Total-asset coverage ratio: 67.14; rating input score 99; 99th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 68; 68th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: Limited
- Revenue growth: 200% per year; rating input score 100; 100th percentile among comparable filings
- Asset growth: 200% per year; rating input score 100; 100th percentile among comparable filings
Details
- Where the money goes: 0% of revenue deployed · 0% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 3 filed program accomplishments
- Leadership: top reported pay $0 · 5 people listed
- Consistency: 8 of 8 current checks pass
- Schedules: 3 filed schedules
- Filing history: 2 filing years from 2023 to 2024
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Financial Efficiency: Mission deployment rate scored 0/100.
- High — Financial Efficiency: Program expense ratio scored 0/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.